Mr. Kash is a co-founder and Partner of Two River. Since September 2004, Mr. Kash has served as the President of Two River's managing member, Two River Group Management, LLC, and served as its Chairman until April 2008. Mr. Kash is also the President and Chairman of Riverbank Capital Securities, Inc., a FINRA member broker dealer ("Riverbank") that has raised over $200 million since its inception in September 2005, including more than $80 million for Two River's Portfolio Companies.

From 1992 until 2004, Mr. Kash was a Senior Managing Director of Paramount BioCapital, Inc., a FINRA member broker dealer, and Paramount BioCapital Investments, LLC, a biotechnology focused venture capital company. Mr. Kash also served as a member of the General Partner of the Orion Biomedical Fund, LP, a private equity fund.

Mr. Kash currently serves as Chairman of the Board of Directors of Nile Therapeutics, Inc. (NASDAQ:NLTX) and as a director of Arno Therapeutics, Inc. (OTCBB:LRRI.OB), and Danube Pharmaceuticals, Inc. He was also a co-founder and former Vice Chairman of Javelin Pharmaceuticals, Inc. (AMEX:JAV).

Mr. Kash served as an Adjunct Professor of Entrepreneurship and International Venture Capital at the Wharton School of Business at the University of Pennsylvania from 1996-2000. He was also Entrepreneur in Residence at Pace University and at Ball State University in May 2002. Mr. Kash served as a Professor of Entrepreneurship at the Sy Syms School of Business from 2003-2005, as well as Visiting Professor of Entrepreneurship at the Graduate School of Business at Nihon University in Tokyo. He is also the author of two books: Make Your Own Luck (2001 Prentice Hall), and Freedom From Disease (2008 - St. Martin's Press).

Mr. Kash currently serves on the Board of Keren-Or, a charity for blind and multi-handicapped children, and is active in a variety of other charities, including Kids Kicking Cancer and Cancer Schmancer. He earned his B.S. in Management Science from SUNY Binghamton and his M.B.A. in Banking and International Finance from Pace University. He is currently writing his thesis for his Doctorate of Education.

The Future of Medicine and Biotechnology